Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Bethesda, MD 20892, USA.
Vaccine. 2013 Aug 20;31(37):3987-94. doi: 10.1016/j.vaccine.2013.05.088. Epub 2013 Jun 4.
We have established a new reporter gene-based RSV neutralization test using Renilla luciferase. The RSV-Luciferase Neutralization Test (RSV-Luc-NeuT) is a simple, rapid, high throughput, and less labor intensive functional serological assay than the traditional RSV-PRNT, capable of measuring a broad range of anti-RSV neutralizing antibodies targeting both RSV-F and RSV-G proteins. Specificity and sensitivity of the RSV-Luc-NeuT are comparable to the RSV-PRNT. Panels of pre-vaccination and post-vaccination animal sera, monoclonal antibodies and animal polyclonal anti-RSV sera confirmed assay specificity. A panel of 60 human sera demonstrated high assay sensitivity for measurement of RSV neutralizing antibodies that strongly correlated with the RSV-PRNT titers (R(2)=0.864). Neutralization in the presence of guinea pig complement (GPC) increased PRNT titers more than the RSV-Luc-NeuT neutralizing antibody titers for these human sera. This newly developed simple, high throughput, RSV-Luc-NeuT could be easily automated and applied in measurement of RSV neutralization titers in large vaccine trials.
我们建立了一种新的基于荧光素酶的 RSV 中和试验,用于检测 RSV 中和抗体。与传统的 RSV-PRNT 相比,该方法具有简单、快速、高通量、劳动强度低等优点,能够检测针对 RSV-F 和 RSV-G 蛋白的广泛中和抗体。RSV-Luc-NeuT 的特异性和灵敏度与 RSV-PRNT 相当。预接种和接种后动物血清、单克隆抗体和动物多克隆抗 RSV 血清的面板证实了该检测方法的特异性。一组 60 个人类血清样本的检测结果表明,该方法对 RSV 中和抗体的检测具有较高的灵敏度,与 RSV-PRNT 滴度呈强相关性(R²=0.864)。在豚鼠补体(GPC)存在的情况下,中和作用使 PRNT 滴度增加的幅度大于 RSV-Luc-NeuT 中和抗体滴度。这种新开发的简单、高通量的 RSV-Luc-NeuT 可以很容易地自动化,并应用于大规模疫苗试验中 RSV 中和滴度的测量。